Sellas Life Sciences Group Inc (SLS)

Cost of Revenue

$0.00

TTM · Period ending: · USD

SLS logo

SLS Cost of Revenue

Latest reported$0.00
SLS TTM Cost of Revenue ($0.00 → $0.00)
High-resolution chart · PNG

SLS cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Sellas Life Sciences Group Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100,000
100,000
100,000
200,000
200,000
200,000
200,000
100,000
0
0
100,000
200,000
300,000
300,000
200,000
100,000
0
0
0
0
0
0
0
0
0
861,000
861,000
1,329,000
1,722,000
1,339,000
1,586,000
1,465,000
1,403,000
1,144,000
1,198,000
8,837,000
8,506,000
8,287,000
13,514,000
11,211,000
16,821,000
16,821,000
11,293,000
5,610,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.